IFN-λ endocytosis and IFN-λ responsive promoter activation are dependent on cholesterol

Cytokine

Volumn 51, Issue 1, 2010, Pages 93-100

  Cho, Okki ^a   Hong, Seung Ho ^a   Kim, Jung Sik ^a   Yoon, Joon Kee ^a   Kim, Kyongmin ^a   Chwae, Yong Joon ^a   Shin, Ho Joon ^a   Park, Sun ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Cholesterol; Dynamin; Endocytosis; IL 28 29; Transcriptional activation

Indexed keywords

CHOLESTEROL; INTERLEUKIN 29; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENDOCYTOSIS; GENE ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CHOLESTEROL; DYNAMINS; ENDOCYTOSIS; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; KINETICS; PROMOTER REGIONS, GENETIC; RHO GTP-BINDING PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 77953362053     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.03.004     Document Type: Article

References (36)

1. Weber M., Blair E., Simpson C.V., O'Hara M., Blackburn P.E., Rot A., et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004, 15:2492-2508.
2. Bonecchi R., Locati M., Galliera E., Vulcano M., Sironi M., Fra A.M., et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 2004, 172:4972-4976.
3. Dubois S., Mariner J., Waldmann T.A., Tagaya Y. IL-15R[alpha] recycles and presents IL-15 in trans to neighboring cells. Immunity 2002, 17:537-547.
4. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003, 5:410-421.
5. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 2007, 8:603-612.
6. Claudinon J., Monier M.N., Lamaze C. Interfering with interferon receptor sorting and trafficking: impact on signaling. Biochimie 2007, 89:735-743.
7. Stang E., Blystad F.D., Kazazic M., Bertelsen V., Brodahl T., Raiborg C., et al. Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits. Mol Biol Cell 2004, 15:3591-3604.
8. Puthenveedu M.A., von Zastrow M. Cargo regulates clathrin-coated pit dynamics. Cell 2006, 127:113-124.
9. Lamaze C., Dujeancourt A., Baba T., Lo C.G., Benmerah A., Dautry-Varsat A. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 2001, 7:661-671.
10. Sabharanjak S., Sharma P., Parton R.G., Mayor S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2002, 2:411-423.
11. Simpson J.C., Smith D.C., Roberts L.M., Lord J.M. Expression of mutant dynamin protects cells against diphtheria toxin but not against ricin. Exp Cell Res 1998, 239:293-300.
12. Naslavsky N., Weigert R., Donaldson J.G. Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell 2004, 15:3542-3552.
13. Collins R.F., Touret N., Kuwata H., Tandon N.N., Grinstein S., Trimble W.S. Uptake of oxLDL by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis. J Biol Chem 2009.
14. Sadir R., Lambert A., Lortat-Jacob H., Morel G. Caveolae and clathrin-coated vesicles: two possible internalization pathways for IFN-gamma and IFN-gamma receptor. Cytokine 2001, 14:19-26.
15. Yang K., Puel A., Zhang S., Eidenschenk C., Ku C.L., Casrouge A., et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005, 23:465-478.
16. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006, 80:4501-4509.
17. Numasaki M., Tagawa M., Iwata F., Suzuki T., Nakamura A., Okada M., et al. IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol 2007, 178:5086-5098.
18. Megjugorac N.J., Gallagher G.E., Gallagher G. Modulation of human plasmacytoid DC function by IFN-{lambda}1 (IL-29). J Leukoc Biol 2009.
19. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
20. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003, 4:69-77.
21. Hong S.H., Cho O., Kim K., Shin H.J., Kotenko S.V., Park S. Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res 2007, 126:245-249.
22. Hong S.H., Kim J.-S., Park S. Generation and characterization of monoclonal antibodies against human interferon-lambda1. Immune Netw 2008, 8:7-12.
23. Shogomori H., Futerman A.H. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 2001, 276:9182-9188.
24. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006, 10:839-850.
25. Tkachenko E., Lutgens E., Stan R.V., Simons M. Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J Cell Sci 2004, 117:3189-3199.
26. Veettil M.V., Sharma-Walia N., Sadagopan S., Raghu H., Sivakumar R., Naranatt P.P., et al. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J Virol 2006, 80:11432-11446.
27. Ramsauer K., Farlik M., Zupkovitz G., Seiser C., Kroger A., Hauser H., et al. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci USA 2007, 104:2849-2854.
28. Polo S., Di Fiore P.P. Endocytosis conducts the cell signaling orchestra. Cell 2006, 124:897-900.
29. Quirin K., Eschli B., Scheu I., Poort L., Kartenbeck J., Helenius A. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 2008, 378:21-33.
30. Chadda R., Howes M.T., Plowman S.J., Hancock J.F., Parton R.G., Mayor S. Cholesterol-sensitive Cdc42 activation regulates actin polymerization for endocytosis via the GEEC pathway. Traffic 2007, 8:702-717.
31. Riento K., Frick M., Schafer I., Nichols B.J. Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J Cell Sci 2009, 122:912-918.
32. Marchetti M., Monier M.N., Fradagrada A., Mitchell K., Baychelier F., Eid P., et al. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol Biol Cell 2006, 17:2896-2909.
33. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008, 9:361-368.
34. Urs N.M., Jones K.T., Salo P.D., Severin J.E., Trejo J., Radhakrishna H. A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors. J Cell Sci 2005, 118:5291-5304.
35. Lebrand C., Corti M., Goodson H., Cosson P., Cavalli V., Mayran N., et al. Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J 2002, 21:1289-1300.
36. Subramaniam P.S., Johnson H.M. Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha. J Immunol 2002, 169:1959-1969.